1. Skip to content

Category: Featured Story

  • Clinical Trial Results Could Lead to New Mesothelioma “Standard of Care”

    In May, MesotheliomaHelp reported researchers announced that in preliminary results of a clinical trial for mesothelioma patients the patients had “a significantly longer survival.” Now, data from that trial of patients receiving the combination treatment of  bevacizumab with pemetrexed/cisplatin supports turning this triplet combination treatment into the new “standard of care.” In the findings presented …

    Label: Featured Story

    Posted on Monday, Sep 21, 2015
  • “Basket Study” May Open Doors for Clinical Trials for Mesothelioma Patients

    Memorial Sloan-Kettering Cancer Center (MSKCC) is breaking the mold with a new type of clinical trial, known as a “basket study.” Whereas traditional trials target a particular cancer, MSKCC is leading the way by offering clinical trials for anti-cancer drugs that focus on a specific biomarker or genetic mutation, regardless of the type of cancer. …

    Label: Featured Story

    Posted on Thursday, Sep 10, 2015
  • Can Researchers Restore Mesothelioma Cells Back to Normal Cells?

    Mesothelioma is one of the most aggressive cancers, and one of the most challenging to treat. The cancer cells overwhelm the healthy cells and immune system and quickly spread throughout the body leaving patients with limited treatment options. Researchers are diligently working on treatments that will intercept or stop the uncontrolled growth of cancer cells. …

    Label: Featured Story

    Posted on Monday, Sep 7, 2015
Load More News Load Older News